Director Declaration
Updated : 11:29
This regulatory news is for Private Investors only
RNS Number : 8449V
Spire Healthcare Group PLC
05 December 2019
Spire Healthcare Group plc
(the "Company")
5 December 2019
Director Declaration
Spire Healthcare Group plc announces that Garry Watts, Non-Executive Chairman of the Company, will be appointed as a non-executive director and senior independent director of Circassia Pharmaceuticals plc, a company listed on AlM, with effect from 2 March 2020.
This announcement is made in accordance with Listing Rule 9.6.14.
Contact:
Cora McCallum
Head of Investor Relations
020 7427 9169
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.